HER2 Negative

What HER2 Negative Means

HER2 Negative means that cancer cells have little or no HER2 protein on their surface. HER2 stands for human epidermal growth factor receptor 2, a protein that helps control how cells grow and divide. In some cancers, especially breast cancer, cells have too much HER2, which can make the cancer grow faster. When cancer is HER2 negative, it means the cells do not have this extra protein, and they may grow more slowly.

Why HER2 Negative Matters in Cancer Care

Knowing whether a cancer is HER2 negative helps doctors decide the best treatment plan. HER2 negative cancers often respond differently to treatments than HER2 positive cancers. For example, HER2 negative breast cancers may be treated with hormone therapies if they are also hormone receptor positive. Some newer targeted therapies, like datopotamab deruxtecan and elacestrant dihydrochloride, are approved for treating breast cancers that are hormone receptor positive and HER2 negative. Understanding HER2 status helps avoid treatments that target HER2 when they wouldn’t be effective.

What Patients Might See or Hear About HER2 Negative

Patients might hear the term HER2 negative during diagnosis, treatment planning, or when discussing lab test results. It often appears in pathology reports or treatment summaries. You may also hear related terms like hormone receptor positive (HR+) or estrogen receptor positive (ER+), which often go together with HER2 negative in breast cancer. If your cancer is described as HER2 negative, it’s important to ask your care team how this affects your treatment options and what it means for your outlook.

Where the Term HER2 Negative May Appear

HER2 negative status is commonly reported in pathology reports after a biopsy or surgery. It may also appear in treatment plans, clinical trial descriptions, or drug information pages, especially for breast cancer. Some lab tests, like the 21-Gene Signature (Oncotype DX), focus on early-stage breast cancers that are ER positive and HER2 negative to help predict the risk of cancer returning and guide treatment decisions.

What HER2 Negative Does Not Automatically Mean

HER2 negative is not a diagnosis by itself and does not tell the whole story about the cancer. It does not guarantee how the cancer will behave or respond to treatment. Other factors like tumor size, grade, hormone receptor status, and overall health also matter. HER2 negative cancers can still grow, spread, or come back, so it’s important to consider this term as part of a bigger picture.

How to Use This Information and Next Steps

If you see HER2 negative in your medical records or hear it from your care team, the best next step is to ask what it means for your specific cancer and treatment plan. This term helps guide treatment but does not decide what is safe or effective for you personally. Your care team can explain how HER2 status fits with other test results and what treatments might be recommended. Understanding HER2 negative status can help you feel more informed and involved in your care decisions.